Organization of GPI-anchored proteins at the cell surface and its physiopathological relevance

References

• Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. 2009. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 119:1438–1449.
   PubMed Web of Science ®Google Scholar
• Almeida AM, Murakami Y, Baker A, Maeda Y, Roberts I, Kinoshita T, Layton DM, Karadimitris A. 2006. Targeted molecular therapy for inherited glycosylphosphatidylinositol deficiency. Blood 108:148a–148a.
   Web of Science ®Google Scholar
• Antony AC. 1996. Folate receptors. Annu Rev Nutr. 16:501–521.
   PubMed Web of Science ®Google Scholar
• Assaraf YG, Leamon CP, Reddy JA. 2014. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 17:89–95.
   PubMed Web of Science ®Google Scholar
• Atkinson CJ, Zhang K, Munn AL, Wiegmans A, Wei MQ. 2016. Prion protein scrapie and the normal cellular prion protein. Prion 10:63–82.
   PubMed Web of Science ®Google Scholar
• Bast RC, Jr, Hennessy B, Mills GB. 2009. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 9:415–428.
   PubMed Web of Science ®Google Scholar
• Bate C, Nolan W, Williams A. 2016a. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation. Prion 10:127–130.
   PubMed Web of Science ®Google Scholar
• Bate C, Nolan W, Williams A. 2016b. Sialic acid on the glycosylphosphatidylinositol anchor regulates PrP-mediated cell signaling and prion formation. J Biol Chem. 291:160–170.
   PubMed Web of Science ®Google Scholar
• Blasi F, Sidenius N. 2010. The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett. 584:1923–1930.
   PubMed Web of Science ®Google Scholar
• Bonnon C, Wendeler MW, Paccaud JP, Hauri HP. 2010. Selective export of human GPI-anchored proteins from the endoplasmic reticulum. J Cell Sci. 123:1705–1715.
   PubMed Web of Science ®Google Scholar
• Boshnjaku V, Shim KW, Tsurubuchi T, Ichi S, Szany EV, Xi G, Mania-Farnell B, McLone DG, Tomita T, Mayanil CS. 2012. Nuclear localization of folate receptor alpha: a new role as a transcription factor. Sci Rep. 2:980.
   PubMed Web of Science ®Google Scholar
• Boucrot E, Ferreira AP, Almeida-Souza L, Debard S, Vallis Y, Howard G, Bertot L, Sauvonnet N, McMahon HT. 2015. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature. 517:460–465.
   PubMed Web of Science ®Google Scholar
• Bradley JE, Chan JM, Hagood JS. 2013. Effect of the GPI anchor of human Thy-1 on antibody recognition and function. Lab Invest. 93:365–374.
   PubMed Web of Science ®Google Scholar
• Brameshuber M, Weghuber J, Ruprecht V, Gombos I, Horvath I, Vigh L, Eckerstorfer P, Kiss E, Stockinger H, Schutz GJ. 2010. Imaging of mobile long-lived nanoplatforms in the live cell plasma membrane. J Biol Chem. 285:41765–41771.
   PubMed Web of Science ®Google Scholar
• Caiolfa VR, Zamai M, Malengo G, Andolfo A, Madsen CD, Sutin J, Digman MA, Gratton E, Blasi F, Sidenius N. 2007. Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol. 179:1067–1082.
   PubMed Web of Science ®Google Scholar
• Campana V, Caputo A, Sarnataro D, Paladino S, Tivodar S, Zurzolo C. 2007. Characterization of the properties and trafficking of an anchorless form of the prion protein. J Biol Chem. 282:22747–22756.
   PubMed Web of Science ®Google Scholar
• Campana V, Sarnataro D, Fasano C, Casanova P, Paladino S, Zurzolo C. 2006. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J Cell Sci. 119:433–442.
   PubMed Web of Science ®Google Scholar
• Campana V, Sarnataro D, Zurzolo C. 2005. The highways and byways of prion protein trafficking. Trends Cell Biol. 15:102–111.
   PubMed Web of Science ®Google Scholar
• Castillon GA, Watanabe R, Taylor M, Schwabe TME, Riezman H. 2009. Concentration of GPI-anchored proteins upon ER exit in yeast. Traffic. 10:186–200.
   PubMed Web of Science ®Google Scholar
• Catino MA, Paladino S, Tivodar S, Pocard T, Zurzolo C. 2008. N- and O-glycans are not directly involved in the oligomerization and apical sorting of GPI proteins. Traffic. 9:2141–2150.
   PubMed Web of Science ®Google Scholar
• Chang WJ, Rothberg KG, Kamen BA, Anderson RGW. 1992. Lowering the cholesterol content of Ma104 cells inhibits receptor-mediated transport of folate. J Cell Biol. 118:63–69.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Mayor S. 2001. The GPI-anchor and protein sorting. Cell Mol Life Sci. 58:1969–1987.
   PubMed Web of Science ®Google Scholar
• Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J, Yong EL, Xu HE, Melcher K. 2013. Structural basis for molecular recognition of folic acid by folate receptors. Nature. 500:486–489.
   PubMed Web of Science ®Google Scholar
• Chesebro B, Race R, Kercher L. 2005a. Scrapie pathogenesis in brain and retina: Effects of prion protein expression in neurons and astrocytes. J Neurovirol. 11:476–480.
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, et al. 2005b. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435–1439.
   PubMed Web of Science ®Google Scholar
• Chiyonobu T, Inoue N, Morimoto M, Kinoshita T, Murakami Y. 2014. Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome. J Med Genet. 51:203–207.
   PubMed Web of Science ®Google Scholar
• Chubinskiy-Nadezhdin VI, Efremova TN, Khaitlina SY, Morachevskaya EA. 2013. Functional impact of cholesterol sequestration on actin cytoskeleton in normal and transformed fibroblasts. Cell Biol Int. 37:617–623.
   PubMed Web of Science ®Google Scholar
• Corsaro A, Bajetto A, Thellung S, Begani G, Villa V, Nizzari M, Pattarozzi A, Solari A, Gatti M, Pagano A, et al. 2016. Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells. Oncotarget. 7:38638–38657.
   PubMedGoogle Scholar
• Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N. 2003. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22:5994–6003.
   PubMed Web of Science ®Google Scholar
• D'Alessio S, Blasi F. 2009. The urokinase receptor as an entertainer of signal transduction. Front Biosci (Landmark Ed). 14:4575–4587.
   PubMed Web of Science ®Google Scholar
• Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. 2008. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev. 34:122–136.
   PubMed Web of Science ®Google Scholar
• Davidson B, Trope CG, Reich R. 2012. Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol. 2:33.
   PubMedGoogle Scholar
• de Geus SW, Baart VM, Boonstra MC, Kuppen PJ, Prevoo HA, Mazar AP, Bonsing BA, Morreau H, van de Velde CJ, Vahrmeijer AL, et al. 2017. Prognostic impact of urokinase plasminogen activator receptor expression in pancreatic cancer: malignant versus stromal cells. Biomark Insights. 12:1177271917715443.
   PubMed Web of Science ®Google Scholar
• Desmoulin SK, Hou Z, Gangjee A, Matherly LH. 2012. The human proton-coupled folate transporter: Biology and therapeutic applications to. Cancer Biol Ther. 13:1355–1373.
   PubMed Web of Science ®Google Scholar
• Edvardson S, Murakami Y, Nguyen TT, Shahrour M, St-Denis A, Shaag A, Damseh N, Le Deist F, Bryceson Y, Abu-Libdeh B, et al. 2017. Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability. J Med Genet. 54:196–201.
   PubMed Web of Science ®Google Scholar
• Fujiwara I, Murakami Y, Niihori T, Kanno J, Hakoda A, Sakamoto O, Okamoto N, Funayama R, Nagashima T, Nakayama K, et al. 2015. Mutations in PIGL in a patient with Mabry syndrome. Am J Med Genet A. 167A:777–785.
   PubMedGoogle Scholar
• Fujiwara T, Ritchie K, Murakoshi H, Jacobson K, Kusumi A. 2002. Phospholipids undergo hop diffusion in compartmentalized cell membrane. J Cell Biol. 157:1071–1081.
   PubMed Web of Science ®Google Scholar
• Gil M, Kim YK, Kim KE, Kim W, Park CS, Lee KJ. 2016. Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity. Biochem Biophys Res Commun. 470:213–219.
   PubMed Web of Science ®Google Scholar
• Gomez-Mouton C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S, Illa I, Bernad A, Manes S, et al. 2001. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA. 98:9642–9647.
   PubMed Web of Science ®Google Scholar
• Gonen N, Assaraf YG. 2012. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat. 15:183–210.
   PubMed Web of Science ®Google Scholar
• Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, et al. 2011. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun. 2.
   PubMed Web of Science ®Google Scholar
• Goswami D, Gowrishankar K, Bilgrami S, Ghosh S, Raghupathy R, Chadda R, Vishwakarma R, Rao M, Mayor S. 2008. Nanoclusters of GPI-anchored proteins are formed by cortical actin-driven activity. Cell135:1085–1097.
   PubMed Web of Science ®Google Scholar
• Gowrishankar K, Ghosh S, Saha S, C R, Mayor S, Rao M. 2012. Active remodeling of cortical actin regulates spatiotemporal organization of cell surface molecules. Cell. 149:1353–1367.
   PubMed Web of Science ®Google Scholar
• Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. 2008. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452:187–193.
   PubMed Web of Science ®Google Scholar
• Hansen L, Tawamie H, Murakami Y, Mang Y, Rehman S, Buchert R, Schaffer S, Muhammad S, Bak M, Nothen MM, et al. 2013. Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability. Am J Hum Genet. 92:575–583.
   PubMed Web of Science ®Google Scholar
• Hartmann LC, Keeney GL, Lingle WL, Christianson TJ, Varghese B, Hillman D, Oberg AL, Low PS. 2007. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer. 121:938–942.
   PubMed Web of Science ®Google Scholar
• Hellriegel C, Caiolfa VR, Corti V, Sidenius N, Zamai M. 2011. Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane. FASEB J. 25:2883–2897.
   PubMed Web of Science ®Google Scholar
• Hou Z, Matherly LH. 2014. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1. Curr Top Membr. 73:175–204.
   PubMed Web of Science ®Google Scholar
• Howard MF, Murakami AT, Pagnamenta C, Daumer-Haas B, Fischer J, Hecht DA, Keays SJ, Knight U, Kolsch U, Kruger S, et al. 2014. Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation. Am J Hum Genet. 94:278–287.
   PubMed Web of Science ®Google Scholar
• Hoyer-Hansen G, Ploug M, Behrendt N, Ronne E, Dano K. 1997. Cell-surface acceleration of urokinase-catalyzed receptor cleavage. Eur J Biochem. 243:21–26.
   PubMedGoogle Scholar
• Huang RY, Chung VY, Thiery JP. 2012. Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Curr Drug Targets. 13:1649–1653.
   PubMed Web of Science ®Google Scholar
• Ilkovski B, Pagnamenta AT, O'Grady GL, Kinoshita T, Howard MF, Lek M, Thomas B, Turner A, Christodoulou J, Sillence D, et al. 2015. Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies. Hum Mol Genet. 24:6146–6159.
   PubMed Web of Science ®Google Scholar
• Jhaveri MS, Rait AS, Chung KN, Trepel JB, Chang EH. 2004. Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment. Mol Cancer Ther. 3:1505–1512.
   PubMed Web of Science ®Google Scholar
• Johnston JJ, Gropman AL, Sapp JC, Teer JK, Martin JM, Liu CF, Yuan X, Ye ZH, Cheng LZ, Brodsky RA, et al. 2012. The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am J Hum Genet. 90:295–300.
   PubMed Web of Science ®Google Scholar
• Johnstone DL, Nguyen TT, Murakami Y, Kernohan KD, Tetreault M, Goldsmith C, Doja A, Wagner JD, Huang L, Hartley T, et al. 2017. Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy. Hum Mol Genet. 26:1706–1715.
   PubMed Web of Science ®Google Scholar
• Kalli KR, Oberg AL, Keeney GL, Christianson TJ, Low PS, Knutson KL, Hartmann LC. 2008. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol. 108:619–626.
   PubMed Web of Science ®Google Scholar
• Kalluri R. 2009. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 119:1417–1419.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
   PubMed Web of Science ®Google Scholar
• Kamen BA, Smith AK. 2004. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev. 56:1085–1097.
   PubMed Web of Science ®Google Scholar
• Kelemen LE. 2006. The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer. 119:243–250.
   PubMed Web of Science ®Google Scholar
• Kinoshita T. 2014. Enzymatic mechanism of GPI anchor attachment clarified. Cell Cycle. 13:1838–1839.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Fujita M. 2016. Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling. J Lipid Res. 57:6–24.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Fujita M, Maeda Y. 2008. Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress. J Biochem. 144:287–294.
   PubMed Web of Science ®Google Scholar
• Knaus A, Awaya T, Helbig I, Afawi Z, Pendziwiat M, Abu-Rachma J, Thompson MD, Cole DE, Skinner S, Annese F, et al. 2016. Rare noncoding mutations extend the mutational spectrum in the PGAP3 subtype of hyperphosphatasia with mental retardation syndrome. Hum Mutat. 37:737–744.
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. 1994. Cell-free formation of protease-resistant prion protein. Nature. 370:471–474.
   PubMed Web of Science ®Google Scholar
• Krawitz PM, Murakami Y, Hecht J, Kruger U, Holder SE, Mortier GR, Delle Chiaie B, De Baere E, Thompson MD, Roscioli T, et al. 2012. Mutations in PIGO, a member of the gpi-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet. 91:146–151.
   PubMed Web of Science ®Google Scholar
• Krawitz PM, Murakami Y, Riesz A, Hietala M, Krüger U, Zhu Na, Kinoshita T, Mundlos S, Hecht J, Robinson PN, et al. 2013. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome. Am J Hum Genet. 92:584–589.
   PubMed Web of Science ®Google Scholar
• Krawitz PM, Schweiger MR, Rodelsperger C, Marcelis C, Kolsch U, Meisel C, Stephani F, Kinoshita T, Murakami Y, Bauer S, et al. 2010. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet. 42:827–829.
   PubMed Web of Science ®Google Scholar
• Kvarnung M, Nilsson D, Lindstrand A, Korenke GC, Chiang SCC, Blennow E, Bergmann M, Stodberg T, Makitie O, Anderlid BM, et al. 2013. A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet. 50:521–528.
   PubMed Web of Science ®Google Scholar
• Kwik J, Boyle S, Fooksman D, Margolis L, Sheetz MP, Edidin M. 2003. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc Natl Acad Sci USA. 100:13964–13969.
   PubMed Web of Science ®Google Scholar
• Lawson VA, Priola SA, Wehrly K, Chesebro B. 2001. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J Biol Chem. 276:35265–35271.
   PubMed Web of Science ®Google Scholar
• Lebreton S, Paladino S, Zurzolo C. 2008. Selective roles for cholesterol and actin in compartmentalization of different proteins in the Golgi and plasma membrane of polarized cells. J Biol Chem. 283:29545–29553.
   PubMed Web of Science ®Google Scholar
• Lee JM, Dedhar S, Kalluri R, Thompson EW. 2006. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 172:973–981.
   PubMed Web of Science ®Google Scholar
• Lengyel E. 2010. Ovarian cancer development and metastasis. Am J Pathol. 177:1053–1064.
   PubMed Web of Science ®Google Scholar
• Linden R. 2017. The Biological function of the prion protein: a cell surface scaffold of signaling modules. Front Mol Neurosci. 10:77.
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. 2008. Physiology of the prion protein. Physiol Rev. 88:673–728.
   PubMed Web of Science ®Google Scholar
• Lingwood D, Simons K. 2010. Lipid rafts as a membrane-organizing principle. Science. 327:46–50.
   PubMed Web of Science ®Google Scholar
• Mahmood N, Mihalcioiu C, Rabbani SA. 2018. Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications. Front Oncol. 8:24.
   PubMed Web of Science ®Google Scholar
• Makrythanasis P, Kato M, Zaki MS, Saitsu H, Nakamura K, Santoni FA, Miyatake S, Nakashima M, Issa MY, Guipponi M, et al. 2016. Pathogenic variants in PIGG cause intellectual disability with seizures and hypotonia. Am J Hum Genet. 98:615–626.
   PubMed Web of Science ®Google Scholar
• Malengo G, Andolfo A, Sidenius N, Gratton E, Zamai M, Caiolfa VR. 2008. Fluorescence correlation spectroscopy and photon counting histogram on membrane proteins: functional dynamics of the glycosylphosphatidylinositol-anchored urokinase plasminogen activator receptor. J Biomed Opt. 13:031215.
   PubMed Web of Science ®Google Scholar
• Marijanovic Z, Caputo A, Campana V, Zurzolo C. 2009. Identification of an intracellular site of prion conversion. Plos Pathog. 5:e1000426.
   PubMed Web of Science ®Google Scholar
• Marshall KE, Hughson A, Vascellari S, Priola SA, Sakudo A, Onodera T, Baron GS. 2017. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection. J Virol. 91:e01686-16.
   PubMed Web of Science ®Google Scholar
• Matherly LH, Hou Z, Deng Y. 2007. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev. 26:111–128.
   PubMed Web of Science ®Google Scholar
• Maydan G, Noyman I, Har-Zahav A, Neriah ZB, Pasmanik-Chor M, Yeheskel A, Albin-Kaplanski A, Maya I, Magal N, Birk E, et al. 2011. Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN. J Med Genet. 48:383–389.
   PubMed Web of Science ®Google Scholar
• Mazzieri R, Pietrogrande G, Gerasi L, Gandelli A, Colombo P, Moi D, Brombin C, Ambrosi A, Danese S, Mignatti P, et al. 2015. Urokinase receptor promotes skin tumor formation by preventing epithelial cell activation of Notch1. Cancer Res. 75:4895–4909.
   PubMed Web of Science ®Google Scholar
• Meslin F, Hamai A, Gao P, Jalil A, Cahuzac N, Chouaib S, Mehrpour M. 2007. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res. 67:10910–10919.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Tawamie H, Maeda Y, Buttner C, Buchert R, Radwan F, Schaffer S, Sticht H, Aigner M, Reis A, et al. 2014. Null mutation in PGAP1 impairing GPI-anchor maturation in patients with intellectual disability and encephalopathy. PLoS Genet. 10:e1004320.
   PubMed Web of Science ®Google Scholar
• Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, et al. 2015. Folate receptor-alpha (FOLR1) expression and function in triple negative tumors. PLoS One. 10:e0122209.
   PubMed Web of Science ®Google Scholar
• Nemoto YL, Morris RJ, Hijikata H, Tsunoyama TA, Shibata ACE, Kasai RS, Kusumi A, Fujiwara TK. 2017. Dynamic meso-scale anchorage of GPI-anchored receptors in the plasma membrane: prion protein vs. Thy1. Cell Biochem Biophys. 75:399–412.
   PubMed Web of Science ®Google Scholar
• O’Shannessy DJ, Somers EB, Maltzman J, Smale R, Fu Y-S. 2012. Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease. Springerplus. 1:22.
   PubMedGoogle Scholar
• Owen DM, Magenau A, Williamson D, Gaus K. 2012. Sub-resolution lipid domains in the plasma membrane influence diffusion and clustering. Biophys J. 102:296a.
   PubMed Web of Science ®Google Scholar
• Owen DM, Rentero C, Rossy J, Magenau A, Williamson D, Rodriguez M, Gaus K. 2010. PALM imaging and cluster analysis of protein heterogeneity at the cell surface. J Biophotonics. 3:446–454.
   PubMed Web of Science ®Google Scholar
• Paladino S, Lebreton S, Lelek M, Riccio P, De Nicola S, Zimmer C, Zurzolo C. 2017. GPI-anchored proteins are confined in subdiffraction clusters at the apical surface of polarized epithelial cells. Biochem J. 474:4075–4090.
   PubMed Web of Science ®Google Scholar
• Paladino S, Lebreton S, Tivodar S, Campana V, Tempre R, Zurzolo C. 2008. Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting. J Cell Sci. 121:4001–4007.
   PubMed Web of Science ®Google Scholar
• Paladino S, Lebreton S, Tivodar S, Formiggini F, Ossato G, Gratton E, Tramier M, Coppey-Moisan M, Zurzolo C. 2014. Golgi sorting regulates organization and activity of GPI proteins at apical membranes. Nat Chem Biol. 10:350–357.
   PubMed Web of Science ®Google Scholar
• Paladino S, Lebreton S, Zurzolo C. 2015. Trafficking and membrane organization of GPI-anchored proteins in health and diseases. Curr Top Membr. 75:269–303.
   PubMed Web of Science ®Google Scholar
• Paladino S, Sarnataro D, Pillich R, Tivodar S, Nitsch L, Zurzolo C. 2004. Protein oligomerization modulates raft partitioning and apical sorting of GPI-anchored proteins. J Cell Biol. 167:699–709.
   PubMed Web of Science ®Google Scholar
• Paladino S, Sarnataro D, Tivodar S, Zurzolo C. 2007. Oligomerization is a specific requirement for apical sorting of glycosyl-phosphatidylinositol-anchored proteins but not for non-raft-associated apical proteins. Traffic. 8:251–258.
   PubMed Web of Science ®Google Scholar
• Pavon MA, Arroyo-Solera I, Cespedes MV, Casanova I, Leon X, Mangues R. 2016. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy. Oncotarget. 7:57351–57366.
   PubMedGoogle Scholar
• Pepe A, Avolio R, Matassa DS, Esposito F, Nitsch L, Zurzolo C, Paladino S, Sarnataro D. 2017. Regulation of sub-compartmental targeting and folding properties of the Prion-like protein Shadoo. Sci Rep. 7.
   Web of Science ®Google Scholar
• Prusiner SB. 1998. Prions. Proc Natl Acad Sci USA. 95:13363–13383.
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, Mckinley MP. 1982. Further purification and characterization of Scrapie prions. Biochemistry. 21:6942–6950.
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Dearmond SJ. 1994. Prion diseases and neurodegeneration. Annu Rev Neurosci. 17:311–339.
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Pan KM, Baldwin MA, Telling GC, Scott M. 1995. The Prion diseases. Aids Res Hum Retrov. 11:S71–S71.
   Web of Science ®Google Scholar
• Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID. 2006. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 127:917–928.
   PubMed Web of Science ®Google Scholar
• Raghupathy R, Anilkumar AA, Polley A, Singh PP, Yadav M, Johnson C, Suryawanshi S, Saikam V, Sawant SD, Panda A, et al. 2015. Transbilayer lipid interactions mediate nanoclustering of lipid-anchored proteins. Cell. 161:581–594.
   PubMed Web of Science ®Google Scholar
• Rivier AS, Castillon GA, Michon L, Fukasawa M, Romanova-Michaelides M, Jaensch N, Hanada K, Watanabe R. 2010. Exit of GPI-anchored proteins from the ER differs in yeast and mammalian cells. Traffic. 11:1017–1033.
   PubMed Web of Science ®Google Scholar
• Sabharanjak S, Sharma P, Parton RG, Mayor S. 2002. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell. 2:411–423.
   PubMed Web of Science ®Google Scholar
• Saha S, Anilkumar AA, Mayor S. 2016. GPI-anchored protein organization and dynamics at the cell surface. J Lipid Res. 57:159–175.
   PubMed Web of Science ®Google Scholar
• Saha S, Lee IH, Polley A, Groves JT, Rao M, Mayor S. 2015. Diffusion of GPI-anchored proteins is influenced by the activity of dynamic cortical actin. Mol Biol Cell. 26:4033–4045.
   PubMed Web of Science ®Google Scholar
• Sahores M, Prinetti A, Chiabrando G, Blasi F, Sonnino S. 2008. uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition. Biochim Biophys Acta. 1778:250–259.
   PubMed Web of Science ®Google Scholar
• Sakaguchi T, Zigman T, Petkovic Ramadza D, Omerza L, Puseljic S, Eres Hrvacanin Z, Miyake N, Matsumoto N, Baric I. 2018. A novel PGAP3 mutation in a Croatian boy with brachytelephalangy and a thin corpus callosum. Hum Genome Var. 5:18005.
   PubMedGoogle Scholar
• Sampaio JL, Gerl MJ, Klose C, Ejsing CS, Beug H, Simons K, Shevchenko A. 2011. Membrane lipidome of an epithelial cell line. Proc Natl Acad Sci USA. 108:1903–1907.
   PubMed Web of Science ®Google Scholar
• Santos TG, Lopes MH, Martins VR. 2015. Targeting prion protein interactions in cancer. Prion. 9:165–173.
   PubMed Web of Science ®Google Scholar
• Sarnataro D, Campana V, Paladino S, Stornaiuolo M, Nitsch L, Zurzolo C. 2004. PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. MBoC Cell. 15:4031–4042.
   Web of Science ®Google Scholar
• Sarnataro D, Pepe A, Zurzolo C. 2017. Cell Biology of Prion Protein. Prog Mol Biol Transl Sci. 150:57–82.
   PubMed Web of Science ®Google Scholar
• Schneider F, Waithe D, Clausen MP, Galiani S, Koller T, Ozhan G, Eggeling C, Sezgin E. 2017. Diffusion of lipids and GPI-anchored proteins in actin-free plasma membrane vesicles measured by STED-FCS. MBoC Cell. 28:1507–1518.
   Google Scholar
• Schutz GJ, Kada G, Pastushenko VP, Schindler H. 2000. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J. 19:892–901.
   PubMed Web of Science ®Google Scholar
• Sengupta P, Jovanovic-Talisman T, Skoko D, Renz M, Veatch SL, Lippincott-Schwartz J. 2011. Probing protein heterogeneity in the plasma membrane using PALM and pair correlation analysis. Nat Methods. 8:969–975.
   PubMed Web of Science ®Google Scholar
• Sengupta P, Lippincott-Schwartz J. 2012. Quantitative analysis of photoactivated localization microscopy (PALM) datasets using pair-correlation analysis. Bioessays. 34:396–405.
   PubMed Web of Science ®Google Scholar
• Seong J, Wang YT, Kinoshita T, Maeda Y. 2013. Implications of lipid moiety in oligomerization and immunoreactivities of GPI-anchored proteins. J Lipid Res. 54:1077–1091.
   PubMed Web of Science ®Google Scholar
• Sharma P, Varma R, Sarasij RC, Ira, Gousset K, Krishnamoorthy M, Rao M, Mayor S. 2004. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell. 116:577–589.
   PubMed Web of Science ®Google Scholar
• Sharonov GV, Balatskaya MN, Tkachuk VA. 2016. Glycosylphosphatidylinositol-anchored proteins as regulators of cortical cytoskeleton. Biochem Moscow. 81:636–650.
   PubMed Web of Science ®Google Scholar
• Sheets ED, Lee GM, Simson R, Jacobson K. 1997. Transient confinement of a glycosylphosphatidylinositol-anchored protein in the plasma membrane. Biochemistry. 36:12449–12458.
   PubMed Web of Science ®Google Scholar
• Simons K, Gerl MJ. 2010. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol. 11:688–699.
   PubMed Web of Science ®Google Scholar
• Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569–572.
   PubMed Web of Science ®Google Scholar
• Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 1:31–39.
   PubMed Web of Science ®Google Scholar
• Singer SJ, Nicolson GL. 1972. The fluid mosaic model of the structure of cell membranes. Science 175:720–731.
   PubMed Web of Science ®Google Scholar
• Siu MK, Kong DS, Chan HY, Wong ES, Ip PP, Jiang L, Ngan HY, Le XF, Cheung AN. 2012. Paradoxical impact of two folate receptors, FRalpha and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome. PLoS One. 7:e47201.
   PubMed Web of Science ®Google Scholar
• Smith HW, Marshall CJ. 2010. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol. 11:23–36.
   PubMed Web of Science ®Google Scholar
• Stevens VL, Tang JH. 1997. Fumonisin B-1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem. 272:18020–18025.
   PubMed Web of Science ®Google Scholar
• Sun M, Northup N, Marga F, Huber T, Byfield FJ, Levitan I, Forgacs G. 2007. The effect of cellular cholesterol on membrane-cytoskeleton adhesion. J Cell Sci. 120:2223–2231.
   PubMed Web of Science ®Google Scholar
• Suzuki KG, Fujiwara TK, Edidin M, Kusumi A. 2007a. Dynamic recruitment of phospholipase C gamma at transiently immobilized GPI-anchored receptor clusters induces IP3-Ca2+ signaling: single-molecule tracking study 2. J Cell Biol. 177:731–742.
   PubMed Web of Science ®Google Scholar
• Suzuki KG, Fujiwara TK, Sanematsu F, Iino R, Edidin M, Kusumi A. 2007b. GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1. J Cell Biol. 177:717–730.
   PubMed Web of Science ®Google Scholar
• Suzuki KG, Kasai RS, Hirosawa KM, Nemoto YL, Ishibashi M, Miwa Y, Fujiwara TK, Kusumi A. 2012. Transient GPI-anchored protein homodimers are units for raft organization and function. Nat Chem Biol. 8:774–783.
   PubMed Web of Science ®Google Scholar
• Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, et al. 2014. The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J Ovarian Res. 7:76.
   PubMed Web of Science ®Google Scholar
• Tanos B, Rodriguez-Boulan E. 2008. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene. 27:6939–6957.
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. 2006. The prion protein and lipid rafts (Review). Mol Membr Biol. 23:89–99.
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. 2007. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins. Semin Cell Dev Biol. 18:638–648.
   PubMed Web of Science ®Google Scholar
• Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, Dearmond SJ, Prusiner SB. 1995. Prion propagation in mice expressing human and chimeric Prp transgenes implicates the interaction of cellular Prp with another protein. Cell 83:79–90.
   PubMed Web of Science ®Google Scholar
• Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454.
   PubMed Web of Science ®Google Scholar
• Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 15:740–746.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 7:131–142.
   PubMed Web of Science ®Google Scholar
• Turek JJ, Leamon CP, Low PS. 1993. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J Cell Sci. 106: 423–430.
   PubMed Web of Science ®Google Scholar
• van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, et al. 2011. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 17:1315–1319.
   PubMed Web of Science ®Google Scholar
• van Zanten TS, Cambi A, Koopman M, Joosten B, Figdor CG, Garcia-Parajo MF. 2009. Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. Proc Natl Acad Sci USA. 106:18557–18562.
   PubMed Web of Science ®Google Scholar
• Vana K, Zuber C, Nikles D, Weiss S. 2007. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol. 27:107–128.
   PubMed Web of Science ®Google Scholar
• Varma R, Mayor S. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature. 394:798–801.
   PubMed Web of Science ®Google Scholar
• Vergote IB, Marth C, Coleman RL. 2015. Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications. Cancer Metastasis Rev. 34:41–52.
   PubMed Web of Science ®Google Scholar
• Wang Q, Qian J, Wang F, Ma Z. 2012. Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis. Oncol Rep. 28:2029–2034.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou BP. 2011. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer. 30:603–611.
   PubMedGoogle Scholar
• Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, et al. 2008. Modification of kidney barrier function by the urokinase receptor. Nat Med. 14:55–63.
   PubMed Web of Science ®Google Scholar
• Yang X, Cheng Z, Zhang L, Wu G, Shi R, Gao Z, Li C. 2017. Prion protein family contributes to tumorigenesis via multiple pathways. Adv Exp Med Biol. 1018:207–224.
   PubMedGoogle Scholar
• Yeats TH, Bacic A, Johnson KL. 2018. Plant glycosylphosphatidylinositol (GPI) anchored proteins at the plasma membrane-cell wall nexus. J Integr Plant Biol. [Epub ahead of print]. doi: 10.1111/Jipb.12659.
   PubMedGoogle Scholar
• Yu SC, Guo ZW, Johnson C, Gu GF, Wu QY. 2013. Recent progress in synthetic and biological studies of GPI anchors and GPI-anchored proteins. Curr Opin Chem Biol. 17:1006–1013.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Tacha DE, Li P, Bremer RE, Chen H, Wei B, Xiao X, Da J, Skinner K, et al. 2014. Folate receptor alpha associated with triple-negative breast cancer and poor prognosis. Arch Pathol Lab Med. 138:890–895.
   PubMed Web of Science ®Google Scholar
• Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, Han Y, Zhang W, Liang J, Wu K. 2014. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer. Int J Cancer. 135:2329–2337.
   PubMed Web of Science ®Google Scholar
• Zurzolo C, Simons K. 2016. Glycosylphosphatidylinositol-anchored proteins: membrane organization and transport. Bba Biomembranes. 1858:632–639.
   PubMed Web of Science ®Google Scholar